Potential biomarkers of ductal carcinoma in situ progression

BACKGROUND: Ductal carcinoma in situ is a non-obligate precursor of invasive breast carcinoma and presents a potential risk of over or undertreatment. Finding molecular biomarkers of disease progression could allow for more adequate patient treatment. We aimed to identify potential biomarkers that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Dettogni, Raquel Spinassé, Stur, Elaine, Laus, Ana Carolina, da Costa Vieira, René Aloísio, Marques, Márcia Maria Chiquitelli, Santana, Iara Viana Vidigal, Pulido, José Zago, Ribeiro, Laura Fregonassi, de Jesus Parmanhani, Narelle, Agostini, Lidiane Pignaton, dos Reis, Raquel Silva, de Vargas Wolfgramm dos Santos, Eldamária, Alves, Lyvia Neves Rebello, Garcia, Fernanda Mariano, Santos, Jéssica Aflávio, do Prado Ventorim, Diego, Reis, Rui Manuel, Louro, Iúri Drumond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017577/
https://www.ncbi.nlm.nih.gov/pubmed/32050925
http://dx.doi.org/10.1186/s12885-020-6608-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017577/
https://www.ncbi.nlm.nih.gov/pubmed/32050925
http://dx.doi.org/10.1186/s12885-020-6608-y

Ejemplares similares